Financials

  • Market Capitalization 3.34 B
  • Employee 798
  • Founded 1993
  • CEO Catherine Owen Adams
  • Website www.acadia.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHG9K0
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
11.61
Relación precio/flujo de caja
4.24

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1560
IDYA
IDEAYA Biosciences, Inc. - Common Stock
36.06 USD-0.14%-5.68%-6.34%+10.68%3.48 B USD
1561
XENE
Xenon Pharmaceuticals Inc. - Common Shares
35.81 USD-1.73%-5.21%-39.67%-12.21%3.47 B USD
1586
VKTX
Viking Therapeutics, Inc. - Common Stock
28.34 USD-0.60%-3.87%-10.60%-13.76%3.31 B USD
1590
ARQT
Arcutis Biotherapeutics, Inc. - Common stock
26.22 USD-1.35%+3.88%+9.02%+27.96%3.30 B USD

ACADIA Pharmaceuticals Inc. - Common Stock

Acadia Pharmaceuticals Inc. es una empresa biofarmacéutica con sede en Del Mar, California.

Noticias